USC Joins Consortium to Look for Blood-vessel-related Biomarkers of Alzheimer’s

USC Joins Consortium to Look for Blood-vessel-related Biomarkers of Alzheimer’s
The University of Southern California's Keck School of Medicine has joined a nationwide consortium of researchers looking for biological factors that could help predict blood-vessel-related health conditions, including dementia and Alzheimer’s. Six institutions besides USC are part of the initiative that the National Institutes of Health started two years ago. Scientists are studying the role that small blood vessel diseases in the brain play in cognitive impairment and dementia with an eye toward developing biomarkers for them. The ultimate goal of the NIH-sponsored research is to help doctors do a better job of diagnosing and predicting the outcomes of these disorders. NIH has dubbed the initiative MarkVCID, for Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia. Two NIH branches — the National Institute of Neurological Disorders and Stroke and the National Institute on Aging — are putting up the $6 million in funding for the five-year program. USC and the other six institutions are trying to improve on current blood-vessel-related biomarkers of cognitive impairment and dementia, and come up with new ones. A  center at Massachusetts General Hospital in Boston is coordinating the work. “We all know that dementia is a tsunami waiting to happen," Steven Greenberg, principal investigator at the Boston center, said in a USC news story. "It’s going to be a true public h
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *